CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women

Gengiah, T. N., Abdool Karim, Q., Harkoo, I., Mansoor, L., Zuma, N. Y., Radebe, P., Samsunder, N., Baxter, C., Maharaj, B., Baum, M. M., Moss, J. A., Pozzetto, B., Hankins, C., & Abdool Karim, S. (2022). CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women. BMJ Open, 12(1), e052880. https://doi.org/10.1136/bmjopen-2021-052880

Authors:

Tanuja Narayansamy Gengiah

Quarraisha Abdool Karim

Ishana Harkoo

Leila Mansoor

Nonhlanhla Yende Zuma

Precious Radebe

Natasha Samsunder

Cheryl Baxter

B Maharaj

Marc M Baum

John A Moss